In Vitro Generation of Megakaryocytes from Engineered Mouse Embryonic Stem Cells

Area of Science:

• Stem cell biology
• Hematopoiesis
• Synthetic biology

Background:

• In vitro differentiation of pluripotent stem cells aids mechanistic studies of cell fate control.
• Reprogramming pluripotent stem cells with synthetic gene circuits can direct cell lineage specification.
• Megakaryocytes are critical progenitor cells for platelet production.

Purpose of the Study:

• To reprogram mouse embryonic stem cells (mESCs) towards the hematopoietic lineage, specifically megakaryocytes.
• To establish a methodology for transgene insertion and stable expression during mESC differentiation.
• To develop a streamlined protocol for mechanistic and therapeutic studies of cell fate control.

Main Methods:

• Preparation of mouse embryonic fibroblasts (MEFs) for mESC culture.
• Culture and preparation of OP9 feeder cells for supporting mESC differentiation.
• Differentiation of mESCs into megakaryocytes using a defined protocol.
• Integrase-mediated docking site insertion for stable transgene integration and expression.

Main Results:

• A robust methodology for growing and differentiating mESCs was established.
• Transgene insertion via an integrase-mediated docking site allowed for stable expression throughout differentiation.
• The protocol demonstrated the potential for mESC reprogramming into megakaryocytes.

Conclusions:

• This study presents a streamlined differentiation protocol for generating megakaryocytes from mESCs.
• The methodology facilitates mechanistic studies of cell fate control and reprogramming.
• The approach holds potential for future therapeutic applications in hematopoiesis.